FDA Clearance Tracker · P140004-S005
Superion® Indirect Decompression System (IDS)
Last checked: Nov 20, 2026Latest source record: Mar 24, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Mar 24, 2017
Approved
Time to decision
78 days
Received Jan 5, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140004-S005
- Device name
- Superion® Indirect Decompression System (IDS)
- Applicant
- Boston Scientific Neuromodulation
- Applicant location
- Valencia, CA
- Received
- Jan 5, 2017
- Decided
- Mar 24, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P140004
Device type
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
Approval for design modifications to the manual instrumentation used to implant the Superion® device.
Source documents
Other decisions for Boston Scientific Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251247 · Decided Aug 7, 2025 · 106 days after receipt
Device type: Generator, Lesion, Radiofrequency (GXD) · Neurology & Neurosurgery
K233801 · Decided Aug 23, 2024 · 268 days after receipt
Device type: Stimulator, Spinal-Cord, Implanted (Pain Relief) (GZB) · Neurology & Neurosurgery
K232415 · Decided Aug 21, 2024 · 376 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.